2025-04-03 - Analysis Report
## Procter & Gamble Co (PG) Stock Report

**0. Executive Summary:**

Procter & Gamble Co (PG) is a consumer goods company that manufactures and markets a wide range of products.  This report analyzes PG's performance against the S&P 500 (VOO), examining its financial metrics, recent price movements, and future prospects.  Key findings show PG outperforming the S&P 500 with consistent profitability and relatively low risk.

**1. Performance Comparison with S&P 500 (VOO):**

Procter & Gamble (PG) demonstrates a cumulative return of 93.14%, exceeding the S&P 500's (VOO) cumulative return of 89.44% by 3.7 percentage points. This places PG's relative outperformance at the 32.6th percentile based on historical data, considering a range of maximum and minimum outperformance.

| Year       | CAGR | MDD  | Alpha | Beta | Cap(B) |
|------------|------|------|-------|------|-------|
| 2015-2017  | 16.0% | 5.0% | -2.0% | 0.1 | 175.5 |
| 2016-2018  | 10.0% | 9.1% | 3.0% | 0.0 | 181.8 |
| 2017-2019  | 46.0% | 9.1% | 27.0% | 0.2 | 253.9 |
| 2018-2020  | 64.0% | 9.1% | 30.0% | 0.1 | 289.9 |
| 2019-2021  | 67.0% | 9.1% | -6.0% | 0.1 | 349.4 |
| 2020-2022  | 25.0% | 67.6% | 14.0% | 0.1 | 331.7 |
| 2021-2023  | 13.0% | 67.6% | -5.0% | 0.3 | 328.9 |
| 2022-2024  | 0.0% | 67.6% | -22.0% | 0.3 | 385.6 |
| 2023-2025  | 19.0% | 50.6% | -22.0% | 0.2 | 394.8 |

The table shows varying CAGR (Compound Annual Growth Rate) and MDD (Maximum Drawdown) across different periods, reflecting market fluctuations.  Alpha, generally positive, indicates potential outperformance relative to the market, while beta, consistently low, suggests lower volatility than the market.


**2. Recent Price Movements:**

* **Closing Price:** $170.58
* **Last Market Price:** $168.36 (down $1.29 from previous close)
* **5-Day Moving Average:** $168.86
* **20-Day Moving Average:** $169.63
* **60-Day Moving Average:** $167.35

The price is currently below its 5-day and 20-day moving averages, suggesting a slight short-term downward trend.  However, it's above the 60-day moving average, implying a longer-term upward trend. The recent price drop is notable and warrants further investigation.


**3. Technical Indicators and Expected Return:**

* **Market Risk Indicator (MRI):** 0.44 (Low Risk)
* **RSI:** 55.43 (slightly above neutral, suggesting neither overbought nor oversold conditions)
* **PPO:** 0.06 (positive, indicating bullish momentum)
* **Relative Strength Change (20-day):** +10.5% (recent short-term upward trend)
* **Expected Return (2+ years):** 38.4% (significant excess return compared to the S&P 500)

The recent price drop of $1.29, while noticeable, doesn't indicate a significant market event like a dramatic crash or rebound based on the provided data.  The high expected return suggests long-term investment potential despite short-term price fluctuations.


**4. Recent Earnings Analysis:**

| Date       | EPS  | Revenue      |
|------------|------|---------------|
| 2025-01-22 | 1.94 | $21.88B       |
| 2024-10-18 | 1.65 | $21.74B       |
| 2024-04-19 | 1.56 | $20.20B       |
| 2024-01-23 | 1.44 | $21.44B       |
| 2023-07-26 | 1.44 | $21.44B       |(There appears to be duplicate data here. This needs clarification.)


Revenue has remained relatively stable, while EPS shows some fluctuation. The significant jump in EPS to $1.94 in 2025-01-22 needs further investigation to understand the underlying drivers.


**5. Financial Information:**

**Revenue and Profitability:**

| Quarter | Revenue  | Profit Margin |
|---------|----------|---------------|
| 2024-12-31 | $21.88B | 52.39%       |
| 2024-09-30 | $21.74B | 52.06%       |
| 2024-06-30 | $20.53B | 49.60%       |
| 2024-03-31 | $20.20B | 51.20%       |
| 2023-12-31 | $21.44B | 52.69%       |

Revenue shows slight seasonal variations. Profit margins are consistently high, indicating strong profitability and efficiency.

**Capital and Profitability:**

| Quarter | Equity   | ROE     |
|---------|----------|---------|
| 2024-12-31 | $51.17B | 9.05%   |
| 2024-09-30 | $51.84B | 7.64%   |
| 2024-06-30 | $50.29B | 6.24%   |
| 2024-03-31 | $50.06B | 7.50%   |
| 2023-12-31 | $48.53B | 7.15%   |

Equity shows some fluctuation, while ROE (Return on Equity) is generally strong, highlighting the efficient use of shareholder capital.


**6. Overall Analysis:**

PG shows strong performance relative to the S&P 500, with consistent profitability and relatively low risk.  The recent price dip is a minor concern but doesn't invalidate the long-term positive outlook.  The high expected return, strong financial metrics, and relatively stable revenue suggest that PG is a solid investment for the long term (2+ years).  However, further investigation into the significant jump in EPS reported on 2025-01-22 and the duplicate data entry is required for a more comprehensive analysis.  The duplicate entry needs to be resolved to ensure accuracy in assessing growth trends.
